{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:16:48Z","timestamp":1791001008620,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Construction Programs of China","doi-asserted-by":"crossref","award":["2014-2016"],"award-info":[{"award-number":["2014-2016"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81370472"],"award-info":[{"award-number":["81370472"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81300517"],"award-info":[{"award-number":["81300517"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81572324"],"award-info":[{"award-number":["81572324"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai City Health Bureau for Youth Scientific Fund Project","award":["20134y100"],"award-info":[{"award-number":["20134y100"]}]},{"name":"Shanghai Rising-Star Program (A type)","award":["15QA1400800"],"award-info":[{"award-number":["15QA1400800"]}]},{"name":"The Science Foundation of Shanghai","award":["13ZR1451800"],"award-info":[{"award-number":["13ZR1451800"]}]},{"name":"The Science Foundation of Shanghai","award":["15ZR1404200"],"award-info":[{"award-number":["15ZR1404200"]}]},{"name":"The State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute","award":["90-12-01"],"award-info":[{"award-number":["90-12-01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bbrc.2016.12.095","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T18:18:11Z","timestamp":1482085091000},"page":"609-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Downregulation of bone morphogenetic protein receptor 2 promotes the development of neuroblastoma"],"prefix":"10.1016","volume":"483","author":[{"given":"Ximao","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuiran","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.12.095_bib1","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Medical progress: recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2016.12.095_bib2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1097-0142(19860715)58:2+<598::AID-CNCR2820581332>3.0.CO;2-C","article-title":"Cancer incidence, survival, and mortality for children younger than age 15 years","volume":"58","author":"Young","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2016.12.095_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.molonc.2008.07.002","article-title":"MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S","volume":"2","author":"Benard","year":"2008","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbrc.2016.12.095_bib4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nature07261","article-title":"Identification of ALK as a major familial neuroblastoma predisposition gene","volume":"455","author":"Mosse","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.12.095_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature09609","article-title":"Integrative genomics identifies LMO1 as a neuroblastoma oncogene","volume":"469","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.12.095_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.2007.13.8925","article-title":"Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study","volume":"27","author":"Matthay","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2016.12.095_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.12.095_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cytogfr.2009.10.015","article-title":"Bone morphogenetic proteins (BMPs): from morphogens to metabologens","volume":"20","author":"Reddi","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbrc.2016.12.095_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jb\/mvp148","article-title":"Bone morphogenetic protein receptors and signal transduction","volume":"147","author":"Miyazono","year":"2010","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.bbrc.2016.12.095_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1227\/01.NEU.0000363722.42097.C2","article-title":"Bone morphogenetic proteins and cancer: review of the literature","volume":"66","author":"Thawani","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bbrc.2016.12.095_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10549-010-0808-0","article-title":"Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4","volume":"124","author":"Ketolainen","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbrc.2016.12.095_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070628","article-title":"Predictive factors of late venous aortocoronary graft failure: ultrastructural studies","volume":"8","author":"Perek","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2016.12.095_bib13","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1158\/1535-7163.MCT-07-0193","article-title":"Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity","volume":"6","author":"Kumar","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2016.12.095_bib14","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1158\/0008-5472.CAN-03-3308","article-title":"An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays","volume":"64","author":"Zhao","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.12.095_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/cr.2013.158","article-title":"Amplification of MPZL1\/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma","volume":"24","author":"Jia","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.bbrc.2016.12.095_bib16","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2016.12.095_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(83)90342-2","article-title":"Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group","volume":"2","author":"Zeltzer","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2016.12.095_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/beta-catenin signaling in development and disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.12.095_bib19","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.284.5415.770","article-title":"Notch signaling: cell fate control and signal integration in development","volume":"284","author":"Artavanis-Tsakonas","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2016.12.095_bib20","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1101\/gad.938601","article-title":"Hedgehog signaling in animal development: paradigms and principles","volume":"15","author":"Ingham","year":"2001","journal-title":"Gene Dev."},{"key":"10.1016\/j.bbrc.2016.12.095_bib21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.12.095_bib22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10428190290012182","article-title":"Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells","volume":"43","author":"Kawamura","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbrc.2016.12.095_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005189","article-title":"Signaling mechanisms of the epithelial-mesenchymal transition","volume":"7","author":"Gonzalez","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbrc.2016.12.095_bib24","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.onc.1210720","article-title":"Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation","volume":"27","author":"Beppu","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2016.12.095_bib25","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1073\/pnas.1101139108","article-title":"Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators","volume":"109","author":"Owens","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.12.095_bib26","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.onc.1210720","article-title":"Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation","volume":"27","author":"Beppu","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2016.12.095_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1756-9966-29-85","article-title":"Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients","volume":"29","author":"Ma","year":"2010","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2016.12.095_bib28","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1038\/sj.onc.1207924","article-title":"Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells","volume":"23","author":"Kim","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2016.12.095_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131467","article-title":"Additive effects of Retinoic Acid (RA) and Bone Morphogenetic Protein 4 (BMP-4) apoptosis signaling in retinoblastoma cell lines","volume":"10","author":"Muller","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2016.12.095_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2051-5960-2-10","article-title":"Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion","volume":"2","author":"Merve","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbrc.2016.12.095_bib31","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1038\/ncomms5444","article-title":"WT1 controls antagonistic FGF and BMP-pSMAD pathways in early renal progenitors","volume":"5","author":"Motamedi","year":"2014","journal-title":"Nat. Commun."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16321398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16321398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T11:44:11Z","timestamp":1589715851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16321398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0006291X16321398"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.12.095","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulation of bone morphogenetic protein receptor 2 promotes the development of neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.12.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}